Masaki Fujieda

1.2k citations

32 papers · 968 indexed · h-index 19

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 18
- Inflammatory mediators and NSAID effects 5
Biochemistry top 5%
Oncology top 10%
- Drug Transport and Resistance Mechanisms 9
- Bone health and treatments 7
Clinical Biochemistry top 10%
Molecular Biology
- Bone Metabolism and Diseases 6
- Genomics, phytochemicals, and oxidative stress 4
- Glutathione Transferases and Polymorphisms 3
Cancer Research
- Carcinogens and Genotoxicity Assessment 2

Co-authors: Tetsuya Kamataki Hiroshi Yamazaki Kazuma Kiyotani Hiroyuki Kaneki Hideo Kunitoh Yoshiki Takahashi Shunsuke Iwano Takashi Ishizaki
Cited by: Pharmacology Biochemistry Oncology
Journals: Biochemical and Biophysical Research Communications (1 paper)Molecular Pharmacology (1 paper)Life Sciences (1 paper)
Partner nations: Japan United States Thailand

In The Last Decade

Masaki Fujieda

31 papers receiving 952 citations

Peers

Countries citing papers authored by Masaki Fujieda

Since Specialization

Citations

This map shows the geographic impact of Masaki Fujieda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Fujieda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Fujieda more than expected).

Fields of papers citing papers by Masaki Fujieda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Fujieda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Fujieda. The network helps show where Masaki Fujieda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Masaki Fujieda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Masaki Fujieda Line = papers co-authored together Masaki Fujieda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Complex Mechanism Underlying Transcriptional Control of the Haplotyped Flavin-containing Monooxygenase 3 (FMO3) Gene in Japanese: Different Regulation between Mutations in 5′-Upstream Distal Region and Common Element in Proximal Region Drug Metabolism and Pharmacokinetics ·Makiko Shimizu,Norie Murayama,Satomi Nagashima,Masaki Fujieda,Hiroshi Yamazaki	2008	12
2	Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3) Pharmacogenetics and Genomics ·C.K. Allerston,Makiko Shimizu,Masaki Fujieda,Elizabeth A. Shephard,Hiroshi Yamazaki,Ian Phillips	2007	31
3	In vivo Evaluation of Coumarin and Nicotine as Probe Drugs to Predict the Metabolic Capacity of CYP2A6 Due to Genetic Polymorphism in Thais Drug Metabolism and Pharmacokinetics ·Sompop Peamkrasatam,Kampon Sriwatanakul,Kazuma Kiyotani,Masaki Fujieda,Hiroshi Yamazaki,Tetsuya Kamataki,Krongtong Yoovathaworn	2006	34
4	Dose dependent inhibitory effects of dietary 8-methoxypsoralen on NNK-induced lung tumorigenesis in female A/J mice Cancer Letters ·Hijiri Takeuchi,Kousuke Saoo,Yoko Matsuda,Masanao Yokohira,Keiko Yamakawa,Yu Zeng,Masafumi Miyazaki,Masaki Fujieda,Tetsuya Kamataki,Katsumi Imaida	2006	32
5	High prevalence of cytochrome P 450 2A61A alleles in a black African population of Ghana European Journal of Clinical Pharmacology* ·Maxwell A. Gyamfi,Masaki Fujieda,Kazuma Kiyotani,Hiroshi Yamazaki,Tetsuya Kamataki	2005	30
6	Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk Biochemical and Biophysical Research Communications ·Tetsuya Kamataki,Masaki Fujieda,Kazuma Kiyotani,Shunsuke Iwano,Hideo Kunitoh	2005	36
7	CYP2A6 IS A PRINCIPAL ENZYME INVOLVED IN HYDROXYLATION OF 1,7-DIMETHYLXANTHINE, A MAIN CAFFEINE METABOLITE, IN HUMANS Drug Metabolism and Disposition ·Miyuki Kimura,Hiroshi Yamazaki,Masaki Fujieda,Kazuma Kiyotani,Honda Goro,Junji Saruwatari,Kazuko Nakagawa,Takashi Ishizaki,Tetsuya Kamataki	2005	23
8	Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers Carcinogenesis ·Masaki Fujieda	2004	169
9	Identification of a Novel Polymorphic Enhancer of the Human CYP3A4 Gene Molecular Pharmacology ·Keiko Matsumura,Tetsuya Saito,Yoshiki Takahashi,Takeshi Ozeki,Kazuma Kiyotani,Masaki Fujieda,Hiroshi Yamazaki,Hideo Kunitoh,Tetsuya Kamataki	2004	78
10	Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients Life Sciences ·Hiroshi Yamazaki,Masaki Fujieda,Masahiro Togashi,Tetsuya Saito,George Preti,John R. Cashman,Tetsuya Kamataki	2004	49
11	Decreased coumarin 7-hydroxylase activities and CYP2A6 expression levels in humans caused by genetic polymorphism in CYP2A6 promoter region (CYP2A69) Pharmacogenetics* ·Kazuma Kiyotani,Hiroshi Yamazaki,Masaki Fujieda,Shunsuke Iwano,Keiko Matsumura,Soisungwan Satarug,Pailin Ujjin,Tsutomu Shimada,F. Peter Guengerich,Andrew Parkinson,Honda Goro,Kazuko Nakagawa,Takashi Ishizaki,Tetsuya Kamataki	2003	58
12	Novel Nonsynonymous Polymorphisms of the CYP1A1 Gene in Japanese Drug Metabolism and Pharmacokinetics ·Tetsuya Saito,Mari Egashira,Kazuma Kiyotani,Masaki Fujieda,Hiroshi Yamazaki,Chikako Kiyohara,Hideo Kunitoh,Tetsuya Kamataki	2003	2
13	Two Novel Haplotypes of CYP2D6 Gene in a Japanese Population Drug Metabolism and Pharmacokinetics ·Hiroshi Yamazaki,Kazuma Kiyotani,Satoshi Tsubuko,Masayuki Matsunaga,Masaki Fujieda,Tetsuya Saito,Jun Miura,Shinichi Kobayashi,Tetsuya Kamataki	2003	30
14	Eighteen Novel Polymorphisms of the CYP2A13 Gene in Japanese Drug Metabolism and Pharmacokinetics ·Masaki Fujieda,Hiroshi Yamazaki,Kazuma Kiyotani,Asami Muroi,Hideo Kunitoh,Hirotoshi Dosaka‐Akita,Yuichi Sawamura,Tetsuya Kamataki	2003	21
15	Two Novel Single Nucleotide Polymorphisms (SNPs) of the FMO3 Gene in Japanese Drug Metabolism and Pharmacokinetics ·Masaki Fujieda,Hiroshi Yamazaki,Masahiro Togashi,Tetsuya Saito,Tetsuya Kamataki	2003	25
16	Novel Mutations of the CYP2A6 Gene in a Thai Population with Lowered Capacity of Coumarin 7-Hydroxylation Drug Metabolism and Pharmacokinetics ·Kazuma Kiyotani,Hiroshi Yamazaki,Masaki Fujieda,Satoshi Daigo,Soisungwan Satarug,Pailin Ujjin,Tetsuya Kamataki	2002	4
17	Twenty One Novel Single Nucleotide Polymorphisms (SNPs) of the CYP2A6 Gene in Japanese and Caucasians Drug Metabolism and Pharmacokinetics ·Kazuma Kiyotani,Masaki Fujieda,Hiroshi Yamazaki,Tsutomu Shimada,F. Peter Guengerich,Andrew Parkinson,Kazuko Nakagawa,Takashi Ishizaki,Tetsuya Kamataki	2002	31
18	A novel mutant allele of the CYP2A6 gene (CYP2A611) found in a cancer patient who showed poor metabolic phenotype towards tegafur Pharmacogenetics* ·Satoshi Daigo,Yoshiki Takahashi,Masaki Fujieda,Noritaka Ariyoshi,Hiroshi Yamazaki,Wasaburo Koizumi,Satoshi Tanabe,Katsunori Saigenji,Sekio Nagayama,Kazumasa Ikeda,Yasuhiko Nishioka,Tetsuya Kamataki	2002	102
19	Formation of mineralized bone nodules by rat calvarial osteoblasts decreases with donor age due to a reduction in signaling through EP1 subtype of prostaglandin E2 receptor Journal of Cellular Biochemistry ·Masaki Fujieda,Michiaki Kiriu,Shigeki Mizuochi,Ken‐ichi Hagiya,Hiroyuki Kaneki,Hayao Ide	1999	6
20	Phorbol ester-induced production of prostaglandin E2 from phosphatidylcholine through the activation of phospholipase D in UMR-106 cells Bone ·Hiroyuki Kaneki,Junji Yokozawa,Masaki Fujieda,Shigeki Mizuochi,Chikako Ishikawa,Hayao Ide	1998	12

About Masaki Fujieda

Masaki Fujieda is a scholar working on Pharmacology, Oncology and Biochemistry, having authored 32 papers that have together received 968 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (18 papers), Drug Transport and Resistance Mechanisms (9 papers), Bone health and treatments (7 papers), Bone Metabolism and Diseases (6 papers), Inflammatory mediators and NSAID effects (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Glutathione Transferases and Polymorphisms (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Pharmacology (506 citations), Biochemistry (92 citations) and Oncology (312 citations). Masaki Fujieda has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Tetsuya Kamataki, Hiroshi Yamazaki, Kazuma Kiyotani, Hiroyuki Kaneki, Hideo Kunitoh, Yoshiki Takahashi, Shunsuke Iwano, Takashi Ishizaki, Kazuko Nakagawa and Keiko Matsumura. Their work appears in journals such as Biochemical and Biophysical Research Communications, Molecular Pharmacology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact